Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 65


Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.

Hepp P, Andergassen U, Jäger B, Trapp E, Alunni-Fabbroni M, Friedl TW, Hecker N, Lorenz R, Fasching P, Schneeweiss A, Fehm T, Janni W, Rack B.

Anticancer Res. 2016 Sep;36(9):4771-6.


Education in Disaster Management: What Do We Offer and What Do We Need? Proposing a New Global Program.

Khorram-Manesh A, Lupesco O, Friedl T, Arnim G, Kaptan K, Djalali AR, Foletti M, Ingrasia PL, Ashkenazi M, Arculeo C, Fischer P, Hreckovski B, Komadina R, Voigt S, Carlström E, James J; DITAC (Disaster Training Curriculum) partners.

Disaster Med Public Health Prep. 2016 Jul 20:1-20. [Epub ahead of print]


Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.

Jueckstock J, Rack B, Friedl TW, Scholz C, Steidl J, Trapp E, Tesch H, Forstbauer H, Lorenz R, Rezai M, Häberle L, Alunni-Fabbroni M, Schneeweiss A, Beckmann MW, Lichtenegger W, Fasching PA, Pantel K, Janni W; SUCCESS Study Group.

BMC Cancer. 2016 Jul 7;16:401. doi: 10.1186/s12885-016-2454-3.


Biodiversity of green algae covering artificial hard substrate surfaces in a suburban environment: a case study using molecular approaches.

Hallmann C, Hoppert M, Mudimu O, Friedl T.

J Phycol. 2016 Jun 11. doi: 10.1111/jpy.12437. [Epub ahead of print]


Widespread green algae Chlorella and Stichococcus exhibit polar-temperate and tropical-temperate biogeography.

Hodač L, Hallmann C, Spitzer K, Elster J, Faßhauer F, Brinkmann N, Lepka D, Diwan V, Friedl T.

FEMS Microbiol Ecol. 2016 Aug;92(8). pii: fiw122. doi: 10.1093/femsec/fiw122. Epub 2016 Jun 7.


Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.

König A, Vilsmaier T, Rack B, Friese K, Janni W, Jeschke U, Andergassen U, Trapp E, Jückstock J, Jäger B, Alunni-Fabbroni M, Friedl T, Weissenbacher T; SUCCESS STUDY GROUP.

Anticancer Res. 2016 Jun;36(6):3123-30.


Comparison of seroma production in breast conserving surgery with or without intraoperative radiotherapy as tumour bed boost.

Ebner F, Schramm A, Bottke D, Friedl TW, Wiegel T, Fink V, Lato K, Bekes I, Janni W, de Gregorio N.

Arch Gynecol Obstet. 2016 Oct;294(4):861-6. doi: 10.1007/s00404-016-4124-8. Epub 2016 Jun 2.


Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial.

Schröder L, Rack B, Sommer H, Koch JG, Weissenbacher T, Janni W, Schneeweiss A, Rezai M, Lorenz R, Jäger B, Schramm A, Häberle L, Fasching PA, Friedl TW, Beckmann MW, Scholz C.

Geburtshilfe Frauenheilkd. 2016 May;76(5):542-550.


Taxonomic revision and species delimitation of coccoid green algae currently assigned to the genus Dictyochloropsis (Trebouxiophyceae, Chlorophyta).

Škaloud P, Friedl T, Hallmann C, Beck A, Dal Grande F.

J Phycol. 2016 Aug;52(4):599-617. doi: 10.1111/jpy.12422. Epub 2016 Jun 15.


Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.

Schwentner L, Harbeck N, Singer S, Eichler M, Rack B, Forstbauer H, Wischnik A, Scholz C, Huober J, Friedl TW, Weissenbacher T, Härtl K, Kiechle M, Janni W, Fink V.

Breast. 2016 Jun;27:69-77. doi: 10.1016/j.breast.2016.03.003. Epub 2016 Apr 4.


Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study.

Janni W, Harbeck N, Rack B, Augustin D, Jueckstock J, Wischnik A, Annecke K, Scholz C, Huober J, Zwingers T, Friedl TW, Kiechle M.

Br J Cancer. 2016 Apr 12;114(8):863-71. doi: 10.1038/bjc.2016.82. Epub 2016 Mar 31.


Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer.

Janni WJ, Rack B, Terstappen LW, Pierga JY, Taran FA, Fehm T, Hall C, de Groot MR, Bidard FC, Friedl TW, Fasching PA, Brucker SY, Pantel K, Lucci A.

Clin Cancer Res. 2016 May 15;22(10):2583-93. doi: 10.1158/1078-0432.CCR-15-1603. Epub 2016 Jan 5.


Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer.

Jäger BA, Finkenzeller C, Bock C, Majunke L, Jueckstock JK, Andergassen U, Neugebauer JK, Pestka A, Friedl TW, Jeschke U, Janni W, Doisneau-Sixou SF, Rack BK.

Transl Oncol. 2015 Dec;8(6):509-16. doi: 10.1016/j.tranon.2015.11.009.


Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.

Obermeier K, Sachsenweger J, Friedl TW, Pospiech H, Winqvist R, Wiesmüller L.

Oncogene. 2016 Jul 21;35(29):3796-806. doi: 10.1038/onc.2015.448. Epub 2015 Dec 7.


Predictors for a successful external cephalic version: a single centre experience.

Ebner F, Friedl TW, Leinert E, Schramm A, Reister F, Lato K, Janni W, DeGregorio N.

Arch Gynecol Obstet. 2016 Apr;293(4):749-55. doi: 10.1007/s00404-015-3902-z. Epub 2015 Oct 5.


The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.

Widschwendter P, Friedl TW, Schwentner L, DeGregorio N, Jaeger B, Schramm A, Bekes I, Deniz M, Lato K, Weissenbacher T, Kost B, Andergassen U, Jueckstock J, Neugebauer J, Trapp E, Fasching PA, Beckmann MW, Schneeweiss A, Schrader I, Rack B, Janni W, Scholz C.

Breast Cancer Res. 2015 Sep 18;17:129. doi: 10.1186/s13058-015-0639-3.


Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.

Schramm A, Friedl TW, Schochter F, Scholz C, de Gregorio N, Huober J, Rack B, Trapp E, Alunni-Fabbroni M, Müller V, Schneeweiss A, Pantel K, Meier-Stiegen F, Hartkopf A, Taran FA, Wallwiener D, Janni W, Fehm T.

Arch Gynecol Obstet. 2016 Feb;293(2):271-81. doi: 10.1007/s00404-015-3879-7. Epub 2015 Sep 9.


Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer.

Scholz C, Andergassen U, Hepp P, Schindlbeck C, Friedl TW, Harbeck N, Kiechle M, Sommer H, Hauner H, Friese K, Rack B, Janni W.

Breast Cancer Res Treat. 2015 Jun;151(3):569-76. doi: 10.1007/s10549-015-3422-3. Epub 2015 May 13.


Core Competencies in Disaster Management and Humanitarian Assistance: A Systematic Review.

Ripoll Gallardo A, Djalali A, Foletti M, Ragazzoni L, Della Corte F, Lupescu O, Arculeo C, von Arnim G, Friedl T, Ashkenazi M, Fisher P, Hreckovski B, Khorram-Manesh A, Komadina R, Lechner K, Stal M, Patru C, Burkle FM, Ingrassia PL.

Disaster Med Public Health Prep. 2015 Aug;9(4):430-9. doi: 10.1017/dmp.2015.24. Epub 2015 May 5. Review.

Items per page

Supplemental Content

Loading ...
Support Center